Icon (ICLR) Change in Account Payables (2009 - 2021)
Icon's (ICLR) quarterly Change in Account Payables came in at -$10.3 million in Q2 2021, down 211.51% year-over-year from $9.3 million in Q2 2020, and down 255.0% quarter-over-quarter from -$2.9 million in Q1 2021.
Analysis
Icon (ICLR) Change in Account Payables (2009 - 2021) Analysis & Trends
Icon (ICLR) has reported Change in Account Payables for 13 consecutive years, with -$10.3 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Change in Account Payables fell 211.51% year-over-year to -$10.3 million in Q2 2021; TTM through Jun 2021 was -$21.6 million, a 287.41% decrease from a year earlier, with the FY2022 full-year figure at -$944000.0, down 156.12% from the prior year.
- Change in Account Payables was -$10.3 million for Q2 2021 at Icon, down from -$2.9 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $9.3 million in Q2 2020 and troughed at -$10.3 million in Q2 2021.
- A 5-year average of -$434611.1 and a median of -$635000.0 in 2019 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 450.54% in 2017, down 1220.0% in 2017.
- Over 5 years, Change in Account Payables stood at $5.6 million in 2017, then slumped by 136.55% to -$2.0 million in 2018, then surged by 272.79% to $3.5 million in 2019, then sank by 220.41% to -$4.2 million in 2020, then tumbled by 143.96% to -$10.3 million in 2021.
- The last three Change in Account Payables figures came in at -$10.3 million (Q2 2021), -$2.9 million (Q1 2021), and -$4.2 million (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -129,000.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 821,000.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -16.70 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -1.43 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 872,116.56 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -10.33 Mn |
| Mar 31, 2021 | -2.91 Mn |
| Dec 31, 2020 | -4.24 Mn |
| Sep 30, 2020 | -4.10 Mn |
| Jun 30, 2020 | 9.27 Mn |
| Mar 31, 2020 | -897,000.00 |
| Dec 31, 2019 | 3.52 Mn |
| Sep 30, 2019 | -373,000.00 |
| Jun 30, 2019 | -5.11 Mn |
| Mar 31, 2019 | 5.40 Mn |
| Dec 31, 2018 | -2.04 Mn |
| Sep 30, 2018 | 210,000.00 |
| Jun 30, 2018 | 3.43 Mn |
| Mar 31, 2018 | -6.67 Mn |
| Dec 31, 2017 | 5.57 Mn |
| Sep 30, 2017 | 2.36 Mn |
| Jun 30, 2017 | -5.77 Mn |
| Mar 31, 2017 | 4.85 Mn |
| Dec 31, 2016 | 4.00 Mn |
| Sep 30, 2016 | -1.96 Mn |